Results 251 to 260 of about 7,589,999 (429)

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Hispanic and Anglo Patients' Reported Use of Alternative Medicine in the Medical Clinic Context [PDF]

, 2001
Michele B. Lundy, Laura L. Morgan, Kelton Rhoads, R. Curtis Bay   +3 more
openalex   +1 more source

Conventional and complementary alternative medicine therapies for renal anemia: a literature review. [PDF]

Front Endocrinol (Lausanne)
Lu CM, Hsu YH, Lin IH, Kuo KL, Liao JF, Huang HF, Lu PH.   +6 more
europepmc   +1 more source

Complementary and Alternative Medicine [PDF]

Journal of Pain & Palliative Care Pharmacotherapy, 2002
openaire   +3 more sources

Landscape of BRAF transcript variants in human cancer

Molecular Oncology, EarlyView.
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda, Danilo Tatoni, Gianluca Mattei, Alberto Magi, Romina D'Aurizio, Laura Poliseno   +5 more
wiley   +1 more source

Population-Based Survey of Complementary and Alternative Medicine Usage, Patient Satisfaction, and Physician Involvement

, 2000
ROBERT OLDENDICK, Ann L. Coker, DARRYL WIELAND, JAMES I. RAYMOND, JANICE C. PROBST, BRUCE J. SCHELL, CARLEEN H. STOSKOPF   +6 more
openalex   +2 more sources

Complementary and alternative medicine in chronic liver disease [PDF]

, 2001
Leonard B. Seeff, Karen L. Lindsay, Bruce R. Bacon, Thomas F. Kresina, Jay H. Hoofnagle   +4 more
openalex   +1 more source

Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren, Moana Busch, Pedro A. Ruiz, Ermanno Malagola, Valeria Baumeler, Federica Foti, Adelina Gross, Tobias Grütter, Hendrik Edel, Cordelia Schuler, Kristina Handler, Glenn De Lange, Isabelle C. Arnold, Cheryl de Vallière, Klaus Seuwen, Martin Hausmann, Gerhard Rogler   +16 more
wiley   +1 more source

Research into complementary and alternative medicine: problems and potential [PDF]

, 2001
Richard L. Nahin
openalex   +1 more source

Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing. [PDF]

Plants (Basel)
Caballero-Gallardo K, Quintero-Rincón P, Olivero-Verbel J.   +2 more
europepmc   +1 more source